PoliticalRepoPoliticalRepo

France · Question · Question écrite

32600

Question 32600 — pharmacy and medications

openFrance· National Assembly· FR

Introduced

Last action

Status

posée

Sponsors

Subjects

Discovery layer

Source updated

Summary

Ms. Sylvia Pinel questions the Minister of Solidarity and Health about the shortage of drugs against cancer. This highly detrimental situation is observed throughout the country. Out of stock includes intravesical BCG (bacillus Calmette and Guérin), used in the treatment of bladder cancer. Indeed, in 2019, 1,499 medicines were reported in shortage or out of supply to the National Medicines Safety Agency (ANSM), of which 22% concerned oncology. The League Against Cancer continues to warn of the accentuation of this phenomenon which is gaining momentum: 34 times more shortages reported in 2019 than in 2008. While the Government announced in July 2019 a strategy to prevent and combat drug shortages, the situation is hardly improving. Some patients, helpless in the face of the worsening of their condition and the lengthening of the waiting list to benefit from their treatment, are forced to undergo surgery which, in the absence of a shortage, could have been avoided. In addition, health professionals, specifically in cities, highlight a worrying lack of information on the origin, duration and history of these shortages. Also, she wishes to know what measures the Government intends taken to remedy this serious public health issue which endangers the quality and continuity of care.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.